Pricing Log in Create free account
Reset Show values

Graham Defensive Investor

Large, sound companies with an unbroken dividend and earnings growth, at a modest price.

Open in screener How it works

Dividend Growth

Reliable payers with room to keep paying: a decade without a cut, a covered dividend, growing earnings.

Open in screener How it works

High Insider Buying

Companies where three or more insiders bought shares in the open market in the last three months.

Open in screener How it works

Piotroski High Score

Cheap companies whose finances are improving on eight or nine of Piotroski's nine tests.

Open in screener How it works

TTM trailing twelve months Q latest quarter A latest fiscal year D daily, from the latest close

Showing the 10 largest of 12 matches.
1 filter active
median
thirds
Free account

See all 12 matches

This screen shows only its 10 largest companies. A free account shows every match of every screen you run, and keeps one screen for you. No card.

Create free account
Powerpack

Export it, tune it, and hear when it changes

Download any screen to Excel, set your own range on any filter, and get an email the day a company enters or leaves a screen you saved.

Start 7-day free trial

Try Powerpack free for 7 days, then $99 / year ($8.25 a month). Cancel any time.

Also in Powerpack: every quarter, analyst estimates, API & MCP access. Compare plans

Table Snapshots
No.
1 UNH UnitedHealth Group Incorporated Revenue Growth for UNH EPS Growth (diluted) for UNH Net Income Growth for UNH Operating Income Growth for UNH Free Cash Flow Growth for UNH 3Y Reveue Growth (CAGR) for UNH 5Y Revenue Growth (CAGR) for UNH 10Y Revenue Growth (CAGR) for UNH 5Y Net Income Growth (CAGR) for UNH 13.67% 18.46%
2 CVS CVS Health Corporation Revenue Growth for CVS EPS Growth (diluted) for CVS Net Income Growth for CVS Operating Income Growth for CVS Free Cash Flow Growth for CVS 3Y Reveue Growth (CAGR) for CVS 5Y Revenue Growth (CAGR) for CVS 10Y Revenue Growth (CAGR) for CVS 5Y Net Income Growth (CAGR) for CVS 5.51% 13.23%
3 ELV Elevance Health, Inc. Revenue Growth for ELV EPS Growth (diluted) for ELV Net Income Growth for ELV Operating Income Growth for ELV Free Cash Flow Growth for ELV 3Y Reveue Growth (CAGR) for ELV 5Y Revenue Growth (CAGR) for ELV 10Y Revenue Growth (CAGR) for ELV 5Y Net Income Growth (CAGR) for ELV 4.12% 4.55%
4 CI Cigna Group Revenue Growth for CI EPS Growth (diluted) for CI Net Income Growth for CI Operating Income Growth for CI Free Cash Flow Growth for CI 3Y Reveue Growth (CAGR) for CI 5Y Revenue Growth (CAGR) for CI 10Y Revenue Growth (CAGR) for CI 5Y Net Income Growth (CAGR) for CI 9.32% 7.41%
5 HUM Humana Inc. Revenue Growth for HUM EPS Growth (diluted) for HUM Net Income Growth for HUM Operating Income Growth for HUM Free Cash Flow Growth for HUM 3Y Reveue Growth (CAGR) for HUM 5Y Revenue Growth (CAGR) for HUM 10Y Revenue Growth (CAGR) for HUM 5Y Net Income Growth (CAGR) for HUM 90.21% 21.24%
6 CNC Centene Corporation Revenue Growth for CNC EPS Growth (diluted) for CNC Net Income Growth for CNC Operating Income Growth for CNC Free Cash Flow Growth for CNC 3Y Reveue Growth (CAGR) for CNC 5Y Revenue Growth (CAGR) for CNC 10Y Revenue Growth (CAGR) for CNC 5Y Net Income Growth (CAGR) for CNC 5.03% 46.94%
7 MOH Molina Healthcare, Inc Revenue Growth for MOH EPS Growth (diluted) for MOH Net Income Growth for MOH Operating Income Growth for MOH Free Cash Flow Growth for MOH 3Y Reveue Growth (CAGR) for MOH 5Y Revenue Growth (CAGR) for MOH 10Y Revenue Growth (CAGR) for MOH 5Y Net Income Growth (CAGR) for MOH 83.62% 7.70%
8 OSCR Oscar Health, Inc. Revenue Growth for OSCR EPS Growth (diluted) for OSCR Net Income Growth for OSCR Operating Income Growth for OSCR Free Cash Flow Growth for OSCR 3Y Reveue Growth (CAGR) for OSCR 5Y Revenue Growth (CAGR) for OSCR 10Y Revenue Growth (CAGR) for OSCR 5Y Net Income Growth (CAGR) for OSCR 15.47% 114.55%
9 PGNY Progyny, Inc. Revenue Growth for PGNY EPS Growth (diluted) for PGNY Net Income Growth for PGNY Operating Income Growth for PGNY Free Cash Flow Growth for PGNY 3Y Reveue Growth (CAGR) for PGNY 5Y Revenue Growth (CAGR) for PGNY 10Y Revenue Growth (CAGR) for PGNY 5Y Net Income Growth (CAGR) for PGNY 21.23% 41.44%
10 CLOV Clover Health Investments, Corp. Revenue Growth for CLOV EPS Growth (diluted) for CLOV Net Income Growth for CLOV Operating Income Growth for CLOV Free Cash Flow Growth for CLOV 3Y Reveue Growth (CAGR) for CLOV 5Y Revenue Growth (CAGR) for CLOV 10Y Revenue Growth (CAGR) for CLOV 5Y Net Income Growth (CAGR) for CLOV 99.66% 73.48%